|
Originally published In Press as doi:10.1074/jbc.M202254200 on April 8, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22156-22167, June 21, 2002
Regulation of Stress Response Signaling by the N-terminal
Dishevelled/EGL-10/Pleckstrin Domain of Sst2, a Regulator of G
Protein Signaling in Saccharomyces cerevisiae*
Scott A.
Burchett §,
Paul
Flanary ¶,
Christopher
Aston ,
Lixin
Jiang ,
Kathleen H.
Young ,
Peter
Uetz** ,
Stanley
Fields**§§¶¶, and
Henrik G.
Dohlman ¶
From the Department of Pharmacology, Yale University
School of Medicine, New Haven, Connecticut 06536, Neuroscience
Research, Wyeth Ayerst-Research, CN 8000, Princeton, New Jersey
08543-8000, and the ** Departments of Genetics and Medicine
and §§ Howard Hughes Medical Institute,
University of Washington, Seattle, Washington 98195
Received for publication, March 7, 2002, and in revised form, March 21, 2002
 |
ABSTRACT |
All members of the regulator
of G protein signaling (RGS) family contain a conserved core domain
that can accelerate G protein GTPase activity. The RGS in yeast, Sst2,
can inhibit a G protein signal leading to mating. In addition, some RGS
proteins contain an N-terminal domain of unknown function. Here we use
complementary whole genome analysis methods to investigate the function
of the N-terminal Sst2 domain. To identify a signaling pathway
regulated by N-Sst2, we performed genome-wide transcription profiling
of cells expressing this fragment alone and found differences in 53 transcripts. Of these, 40 are induced by N-Sst2, and nearly all contain
a stress response element (STRE) in the promoter region. To identify
components of a signaling pathway leading from N-Sst2 to STREs, we
performed a genome-wide two-hybrid analysis using N-Sst2 as bait and
found 17 interacting proteins. To identify the functionally relevant
interacting proteins, we analyzed all of the available gene deletion
mutants and found three (vps36 , pep12 ,
and tlg2 ) that induce STRE and also repress
pheromone-dependent transcription. We selected
VPS36 for further characterization. A vps36
mutation diminishes signaling by pheromone as well as by downstream
components including the G protein, effector kinase (Ste11), and
transcription factor (Ste12). Conversely, overexpression of Vps36
enhances the pheromone response in sst2 cells but not in
wild type. These findings indicate that Vps36 and Sst2 have opposite
and opposing effects on the pheromone and stress response pathways,
with Vps36 acting downstream of the G protein and independently of Sst2
RGS activity.
 |
INTRODUCTION |
All cells have the capacity to respond to chemical and sensory
stimuli in their environment. In many cases, signal detection occurs
through cell surface receptors coupled to G proteins. One particularly
well characterized example is the pheromone response pathway in yeast
(1). In this case, haploid a and cell types each secrete
a peptide pheromone that binds to receptors on cells of the opposite
type. Pheromone stimulation leads to activation of a G protein, which
entails GTP binding and dissociation of the G and  subunits.
The G moiety activates downstream signaling events required for
mating, including alterations in gene transcription, morphological and
cytoskeletal changes, and cell cycle arrest in G1. Among
the induced genes is SST2, which encodes a feedback
regulator that stimulates G protein GTPase activity and G protein
inactivation (1).
Over the past 5 years, an extensive family of Sst2-related proteins has
been identified in higher eukaryotes (2). In every instance examined,
the region of core-RGS1
homology is both necessary and sufficient for G protein GTPase activating function (3). Some RGS proteins contain additional domains
or motifs that may be recognized by proteins other than G (4-13).
The RGS protein p115RhoGEF has one domain that acts as a
GTPase-accelerating protein for G13 and a second domain that acts as a GDP-GTP exchange factor for RhoA (14, 15). Other RGS
proteins including Egl-10, Eat-16, RGS6, RGS7, RGS9, RGS11, and FlbA,
have large N-terminal segments containing a conserved Dishevelled,
Egl-10, and pleckstrin (DEP) domain (16). Sst2 has two such DEP
regions, composed of residues 50-135 and 279-358. The function of the
RGS DEP domains is not known, but in at least two cases (Egl-10, Sst2)
they appear necessary and sufficient for membrane localization (17,
18). In the case of Sst2, the N-terminal domain can be expressed as a
separate entity, the result of an endoproteolytic processing event
in vivo (18).
Our objective here was to establish a signaling function for the DEP
domain of Sst2, designated N-Sst2. With the completion of the yeast
genome sequence, approaches to the identification of new signaling
pathways have changed dramatically. Analysis of gene function has
become more comprehensive and systematic and can occur at several
levels. First, closely related protein isoforms can be identified
through sequence similarity analysis or through complementation of gene
mutations by functionally similar genes. Second, transcriptional
changes can be monitored under various physiological conditions,
through the use of RNA hybridization arrays (19). Third, signaling
complexes can be identified through the use of two-hybrid screens (20,
21) or through the isolation and sequencing of multiprotein complexes
(22-26). Fourth, the functional significance of each signaling
component can be determined through gene disruption mutations (27).
There are, however, limitations to each of these methods. For instance,
transcription analysis can reveal how different physiological conditions affect a particular signaling pathway but cannot be used to
identify the components of that pathway. Two-hybrid analysis can reveal
the components of a pathway, but it cannot be used to determine how
physiological changes affect the interactions of each component. Thus,
a combined analysis, encompassing multiple whole genome approaches, can
provide highly complementary information about any cellular process.
For instance, a combination of two different high throughput methods,
protein interaction mapping and large scale phenotypic analysis, was
recently used to identify novel DNA repair and DNA damage checkpoint
pathway components in Caenorhabditis elegans (28).
Here we have used a combination of transcription profiling, protein
interaction mapping, and phenotypic analysis of gene disruption mutants
to investigate signaling by the N-terminal Sst2 domain. Our findings
indicate that N-Sst2 modulates the stress response and does so through
proteins not previously recognized to participate in the mating or
stress pathways.
 |
EXPERIMENTAL PROCEDURES |
Strains and Plasmids--
Standard methods for the growth,
maintenance, and transformation of yeast and bacteria and for the
manipulation of DNA were used throughout (29). The yeast
Saccharomyces cerevisiae strains used in this study are
YPH499 (MATa ura3-52 lys2-801am
ade2-101oc trp1- 63 his3- 200
leu2- 1), YDM400 (YPH499, sst2- 2) (30), BY4741
(MATa leu2 met15
ura3 ) and BY4741-derived mutants lacking YLR113W
(HOG1, SSK3), YER188W, YGR018C, YGR040W
(KSS1), YER118C (SHO1, SSU81), YLR417W
(VPS36, VPL11, GRD12,
VAC3), YML038C (YMD8), YMR004W (MVP1),
YJL057C (IKS1), YOR036W (PEP12, VPL6, VPT13, VPS6), YDL186W, YDR319C, YOL018C
(TLG2), YDL180W, YHR158C (KEL1), YIL159W
(BNR1), YOR069W (VPS5, GRD2,
VPT5, PEP10), YMR077C (VPS20,
ASI10, CHM6), YOR089C (VPS21,
VPT21, YPT51), and YJR102C (VPS25) all
from Research Genetics (Huntsville, AL). Gene disruptions were not
available for the remaining two-hybrid hits YLR457C (NBP1) and YGR172C (YIP1).
Expression plasmids used in this study have been described previously
and are pRS315 (CEN, ampR, LEU2)
(31), pRS423 (2 µm, ampR, HIS3) (31),
pRS316-ADH (CEN, ampR, URA3,
ADH1 promoter/terminator) (32), pRS316-ADH-SST2,
pRS316-ADH-SST2-P20L, pRS316-ADH-N-SST2 (SST2 codons 1-392,
plus a Myc epitope tag), pRS316-ADH-C-SST2 (SST2 codons
411-698), pRS315-ADH-C-SST2 (also known as ADHleu-C-SST2) (18),
pRS316-GAL-STE4 (33), and YCp50-STE11-4 (34) (from George Sprague,
University of Oregon). Overexpression of VPS36 and
STE12 was achieved by PCR amplification and subcloning into
the pYES2.1/V5-His-TOPO (2 µm, URA3, GAL1
promoter, CYC1 terminator) (Invitrogen, Carlsbad, CA).
Primers used were 5'-GTG TGT TTT GAA AGT CAT TCT-3' and 5'-ACG AGC AGG
TAA TCA AAC CA-3' (for VPS36) and 5'-GAA TTG TCT TGT TCA CCA
AGG-3' and 5'-CTG GCC CGC ATT TTT AAT TC-3' (for STE12).
pRS423-HSP12-lacZ was constructed by replacing the FUS1
promoter (BamHI-EagI fragment) of
pRS423-FUS1-lacZ with the HSP12 promoter (608 bp immediately
preceding the initiator AUG), which was isolated through PCR
amplification of genomic yeast DNA. The primers used were HSP12F
(5'-AAT AAT CGG CCG ATC CCA CTA ACG GCC CAG CC-3')
containing a synthetic EagI site (indicated in boldface
type) and HSP12R (5'-G CGC GGA TCC CCA CTT TCT TTA GCC
AT TCT TGT TGT ATT TAG TTT TTT TT-3') containing a synthetic
BamHI site, an idealized translation initiation sequence (AXA preceding the initiation codon), and the first
five codons of CYC7 (indicated by underlining) fused in
frame with codon 10 of the lacZ gene.
Two-hybrid N-Sst2 Bait Plasmid
Construction--
Oligonucleotides were designed to PCR-amplify the
N-terminal portion (amino acids 1-392) of Sst2, using pRS316-ADH-Sst2
as the template, the forward primer (5'-CCG GAA TTC ATG GTG GAT AAA AAT AGG ACG-3', containing a synthetic EcoRI site,
indicated in boldface type), and the reverse primer (5'-GTA CCC
ATG GTT ACA TAT GAC CCC TTA ATG TGA A-3', containing a synthetic
NcoI site, indicated in boldface type). The 0.9-kbp product
was cloned in frame downstream of the GAL4 DNA-binding
domain contained in the yeast two-hybrid bait vector pOBD2 (35).
RNA Isolation and Hybridization--
Total RNA was isolated from
yeast strains using RNeasy columns (Qiagen, Valencia, CA), and stored
at 80 °C. Genomic DNA was removed by DNase digestion of 10 µg of
total RNA for 30 min at 37 °C in a 100-µl reaction containing
DNase I (1.4 units; Invitrogen), RNase inhibitor (0.1 units;
Invitrogen), and dithiothreitol (1 mM) in 1× PCR buffer I
(PerkinElmer Life Sciences). DNase was removed by passage through an
RNeasy column (Qiagen).
Amplified, biotin-labeled cRNA was produced from total RNA as described
(36). Briefly, 10 µg of total RNA was incubated for 10 min at
70 °C with a high pressure liquid chromatography-purified oligo(dT)
primer containing a T7 RNA polymerase promoter site (5'-GGC CAG TGA ATT
GTA ATA CGA CTC ACT ATA GGG AGG CGG T-3'; from GENSET Inc., La Jolla,
CA). Following priming, cDNA was prepared using the SuperScript II
cDNA synthesis kit (Invitrogen) with the following conditions: 65 min at 50 °C for first strand synthesis with Superscript II reverse
transcriptase, followed by 150 min at 16 °C for second strand
synthesis with Escherichia coli ligase, E. coli polymerase, and RNase H. cDNA was
purified by phenol/chloroform extraction followed by removal of the
organic fraction using Phase Lock Gel I tubes (5 Prime to 3 Prime Inc.,
Boulder, CO). Biotin-labeled cRNA was transcribed in an in
vitro transcription reaction mixture containing T7 RNA
polymerase (Epicenter, Madison, WI), bio-11-CTP, and bio-11-UTP (Enzo
Laboratories, Farmingdale, NY) for 16 h at 37 °C. The cRNA
product was purified by RNeasy column and then quantitated by UV
absorbance at 260 nm. 15 µg of cRNA was fragmented for 35 min at
95 °C and then added to a 300-µl hybridization mixture containing
bovine serum albumin (0.5 mg/ml) and herring sperm DNA (0.1 mg/ml;
Promega, Madison, WI) in 1× MES. To estimate the sensitivity of the
oligonucleotide arrays, we included 11 in vitro synthesized transcripts (spiked transcripts) in each hybridization (37). 200 µl of hybridization mixture was applied to a Ye6100 subA
GeneChip (Affymetrix, Santa Clara, CA), and hybridization was allowed
to proceed for 20 h at 45 °C on a rotisserie. The sample was
then hybridized sequentially to the Ye6100 subB, subC, and subD
designs, comprising ~6400 yeast genes and open reading frames. When
hybridization was complete, arrays were stained with streptavidin-conjugated phycoerythrin (Molecular Probes, Inc., Eugene,
OR) as described (36). Fluorescence intensity was quantitated using the
Affymetrix GeneChip laser scanner.
The resulting array images were captured in the GeneChip version 3.3 software package and reduced to relative expression values (average
difference values) for each transcript. The spiked transcripts were
used to generate a standard curve of concentration versus their average difference values. The abundance of each transcript (stated in terms of control transcripts per total transcripts) ranged
from 1:300,000 to 1:1,000, calculated by assuming an average RNA size
of 1,000 ribonucleotides. This standard curve was then used to
determine the absolute expression level of the yeast transcripts and is
presented as RNA copies per million total transcripts. Based on the
signal response from these control transcripts, the sensitivity of the
arrays ranged between 1:100,000 and 1:200,000. Consequently, expression
values below 10 RNA copies per million total transcripts are considered
below the limit of accuracy. Final data analysis was performed using
Excel (Microsoft Corp., Redmond, WA). Pairwise comparisons generated
-fold change values. -Fold change values of >4 were considered to be significant.
The arrays include probe sets representing the 5' and 3' regions of the
-actin transcript. The 5' to 3' signal ratios were >0.7 across all
arrays, indicating that the source RNA was of suitable quality.
Two-hybrid Screening--
Transformants containing the
N-Sst2-Gal4 fusion plasmid were mated to a set of ~6,000 colonies,
each expressing a unique full-length open reading frame fused to the
Gal4 activation domain, as described previously (20, 35). The resulting
diploids were transferred to selective plates deficient in histidine
and monitored after 10 days. Proteins identified in two independent
screens were analyzed further.
Growth, Transcription, and Phosphorylation Bioassays--
For
NaCl-dependent growth inhibition, saturated cultures were
diluted to A600 ~ 0.2 and grown to
A600 ~ 0.8 and then treated with either water
or 10 µM -factor (final concentration) for 2 h.
10 µl of cells were spotted onto solid medium containing 0.75 M NaCl (where indicated) either without dilution or diluted 1:10, 1:100, 1:1,000, 1:10,000, and 1:100,000 with water or with 10 µM -factor (where indicated).
For the pheromone-dependent growth inhibition assay (halo
assay), overnight cultures were grown in selective media, and
100 µl was diluted with 2 ml of sterile water, followed by the
addition of an equal volume of 1% (w/v) dissolved agar (55 °C), and
poured onto an agar plate containing the same medium. Sterile filter discs were spotted with synthetic -factor pheromone and placed onto
the nascent lawn to induce growth arrest. The resulting zone of
growth-arrested cells was documented after 2 days.
For pheromone-dependent reporter transcription assays (29),
strains were grown for 36 h in standard dextrose-selective medium and then diluted in selective medium containing galactose to induce expression of Vps36, Ste4, or Ste12. Mid-log phase cells were then
aliquoted (90 µl) to a 96-well plate and mixed with 10 µl of
-factor for 90 min in quadruplicate. For HSP12 reporter
transcription assays, strains were grown in selective medium to mid-log
phase and then aliquoted (85 µl) to a 96-well plate and mixed with 15 µl of 5 M NaCl for 10 min in triplicate. Cells to be
treated with NaCl were maintained at room temperature instead of
30 °C to reduce basal activity of the stress response promoter.
-Galactosidase activity was measured by adding 20 µl of a freshly
prepared solution of 83 µM fluorescein
di- -D-galactopyranoside (Molecular Probes, Inc.; 10 mM stock in Me2SO), 137.5 mM
PIPES, pH 7.2, 2.5% Triton X-100, and incubating for 90 min at
37 °C. The reaction was stopped by the addition of 20 µl of 1 M Na2CO3, and the resulting
fluorescence activity was measured at 485-nm excitation, 530-nm emission.
For Hog1 phosphorylation assays, saturated cultures were diluted to
A600 ~ 0.4, grown for an additional 3-4 h,
and treated with 0.75 M NaCl (final concentration) for 10 min, as indicated. Cells were treated with 10 mM
NaN3, chilled briefly on ice, and harvested by
centrifugation at 2,000 × g for 10 min at 4 °C. The pellets
were resuspended (1.5 × 106 cells/µl) in 1×
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 1%
2-mercaptoethanol, 0.0005% bromphenol blue) and boiled for 10 min. The
cells were disrupted by glass bead vortex homogenization for 4 min and
centrifuged at 16,000 × g for 2 min. The supernatant was
collected and stored at 20 °C. Lysates were reheated at 37 °C
for 20 min before SDS-PAGE and transfer to nitrocellulose. Immunoblots
were probed with the 4G10 anti-phosphotyrosine mouse monoclonal
antibody (05-321; Upstate Biotechnology, Inc., Lake Placid, NY) at
1:1,000 dilution and a horseradish peroxidase-conjugated goat
anti-mouse antibody (Sigma) at 1:3,000 dilution, carried out as
described (29).
Bioinformatics--
For each gene demonstrated to be
differentially expressed in the microarray analysis, a region upstream
of the translation start site (to the nearest stop codon, up to 500 bp)
was analyzed for sequence motifs representing possible promoter
regulatory elements. Most regulatory elements in yeast are found within
this region (38). Alignace was used to search for conserved motifs (39). Genespring (Silicon Genetics, Redwood City, CA) was used to
identify predefined motifs. Genespring was also used for statistical analysis, comparing the frequency of a motif in a gene list with the
upstream regions of all yeast genes. The Transfac data base (Biobase,
Braunschweig, Germany) was used to search for previously identified
transcription factor binding sites.
A number of Vps36 protein homologues were identified from the
nonredundant GenBankTM data base using the advanced BLAST
algorithm and the full-length Vps36 protein sequence as the query.
PSI-BLAST was used to detect weaker, but nonetheless biologically
significant, homologues to Vps36 (40). Multiple alignments of all the
Vps36 homologues were performed with ClustalW (41). The alignment was
formatted in Phylip and imported into TREEVIEW for visualization of the Vps36 family (42). Classical basic nuclear localization signals were
identified using the World Wide Web version of PSORT II (43). The more
sensitive hidden Markov model algorithm utilized in the SMART data base
was used to detect additional signaling domains and motifs within Vps36
and its homologues (16).
 |
RESULTS |
All signaling pathways regulate gene expression. For instance, in
yeast, G protein activation leads to the induction of genes with a
pheromone response element (PRE) in their promoter region. One of the
induced genes encodes Sst2, which is well known to attenuate G protein
signaling through its GTPase accelerating function (44). Regulation of
the G protein requires the C-terminal RGS domain, C-Sst2 (18, 30). The
function of the N-terminal domain is not known. Our aim was to
determine whether N-Sst2 regulates a distinct signaling pathway,
perhaps independently of the G protein. To this end, we sought to
identify genes whose expression changed substantially in cells
containing just the N-Sst2 domain. Our approach was to use
oligonucleotide probe microarrays to monitor the mRNA levels of all
yeast genes, comparing cells that express N-Sst2 with cells that lack
the N-Sst2 domain (express C-Sst2 alone).
An sst2 mutant strain was transformed with plasmids
containing either the N-Sst2 segment (residues 1-392 plus a Myc
epitope tag) or the C-Sst2 segment (residues 411-698), as described
previously (18). Expression was verified by immunoblot analysis with
anti-Myc and anti-Sst2 antibodies, as well as by in
vivo complementation of the sst2 mutation,
which requires co-expression of both N-Sst2 and C-Sst2. To provide
uniform expression under various growth conditions, a constitutive
promoter from ADH1 was used in place of the native
(PRE-containing) promoter from SST2. Cultures in mid-log
phase were collected, and total RNA was isolated. Biotin-labeled cRNA
was prepared and hybridized to an Affymetrix GeneChip set representing
~6,400 genes and open reading frames over four separate chips. The
arrays were then treated with streptavidin-conjugated phycoerythrin,
and fluorescence intensity was measured using the Affymetrix GeneChip
laser scanner, as described under "Experimental Procedures."
Expression profiles in cells containing N-Sst2 or C-Sst2 are shown are
Table I. A comparison of N-Sst2
versus C-Sst2 revealed a >4-fold difference in 53 independent
transcripts (0.82% of all genes), of which 40 increased and 13 decreased ("induced" and "repressed" by N-Sst2, respectively).
Fewer differences were observed in cells treated with pheromone or when
comparing N-Sst2 or C-Sst2 with full-length Sst2 (Fig.
1).2
Thus, N-Sst2 is necessary for the transcriptional regulation of a
discrete set of genes.
View this table:
[in this window]
[in a new window]
|
Table I
Microarray analysis of cells expressing N-Sst2 and C-Sst2
An sst2 mutant strain was transformed with plasmids
containing either the N-Sst2 segment or the C-Sst2 segment, as
described. Biotin-labeled cRNA was hybridized to a GeneChip set
representing 6,412 genes and open reading frames. Units are RNA copies
per million total transcripts. Gene descriptions are derived from YPD.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Stress-dependent reporter
transcription assay: N-Sst2 versus C-Sst2. An
sst2 mutant strain (YDM400) was transformed with a
plasmid containing the stress-activated HSP12 promoter and
lacZ reporter gene (pRS423-HSP12-lacZ) and a
plasmid having no insert (Vector; pRS316-ADH),
N-SST2, C-SST2, full-length SST2, or
the SST2P20L (P20L) mutant. Cells
were grown to mid-log phase, treated with NaCl or water for 10 min, and
assayed for -galactosidase activity. Data shown are typical of three
independent experiments performed in triplicate. Error
bars, ±S.E.
|
|
We then examined whether the 53 genes regulated by N-Sst2 share common
elements in the promoter region. This analysis revealed a CCCCT motif
in 32 of the 40 genes (80%) induced by N-Sst2 (Table II). The CCCCT motif is a core consensus
sequence of the stress response element (STRE), also known as a
UASPDS (45-47). In addition, multiple copies of the motif
were identified in 21 of the 40 N-Sst2-induced genes. In 15 of these
genes, the CCCCT motifs were <60 bp apart. A similar analysis of the
entire yeast genome revealed multiple copies of the motif in 515 of
6,144 genes (8.4%), 212 of which are within 60 bp of one another
(3.4%). Previous gene profiling analysis has demonstrated that most
genes induced upon treatment with NaCl contain the CCCCT sequence (48).
The sequence CCCCT functions in both directions (49). Of the 32 genes
identified here, the motif was found in both the sense (49%) and
antisense (51%) orientations.
View this table:
[in this window]
[in a new window]
|
Table II
Genes induced by N-Sst2 contain a stress-response element
Alignace was used to identify motifs of 8 nucleotides in length within
the 5' intergenic region of each open reading frame. Genespring was
used to search for highly conserved sequence elements, and for
statistical analysis. The Transfac database was used to identify
potential transcription factor binding sites. Starting positions of the
CCCCT and CCCCTTAT motifs are provided, relative to the initiator ATG.
N/C, ratios of transcript numbers for N-Sst2 and C-Sst2.
|
|
Microarray analysis provides a convenient measure of transcriptional
regulation of a large number of genes. However, other methods are
better suited to measure transcriptional regulation of specific genes,
particularly under various physiological conditions or genetic
backgrounds. To expand our analysis of N-Sst2 signaling, we turned to a
reporter transcription assay composed of the HSP12 promoter
and lacZ ( -galactosidase) gene. This promoter was
selected because the microarray data had indicated a substantial
(8.6-fold) difference in HSP12 transcript levels in cells
that express N-Sst2 versus C-Sst2. Moreover, the promoter region of
HSP12 contains five STREs and has been previously used to
monitor gene regulation in response to heat, high salt, and high
osmolarity stress conditions (50).
We initially compared HSP12-lacZ induction in an
sst2 strain transformed with either N-Sst2, C-Sst2,
full-length Sst2, or the empty vector (no Sst2 expressed). In addition,
we tested a gain-of-function allele, SST2P20L.
This mutation confers dominant pheromone resistance, through an as yet
uncharacterized mechanism (51). As shown in Fig. 1, there was a 6-fold
difference in activity in cells expressing N-Sst2 versus C-Sst2 (70,302 and 11,613 units of activity, respectively). Full-length Sst2 yielded
an intermediate level of activity (25,209 units), slightly below that
of cells lacking Sst2 (empty vector, 37,156 units). The
Sst2P20L mutant behaved like the vector control. Thus, the
results of the reporter transcription assay corroborate the differences
observed by microarray analysis, in which the basal level of expression was highest for N-Sst2 and lowest for C-Sst2. An intermediate basal
activity was observed for full-length Sst2 (Fig. 1).
We then examined if N-Sst2 could modulate HSP12-lacZ
induction by exposure to high concentrations of salt (0.75 M NaCl), a known activator of the stress response pathway.
As shown in Fig. 1, there was minimal salt induction of
HSP12-lacZ in cells expressing N-Sst2. In contrast, there
was a larger induction in cells expressing full-length Sst2 (2.6-fold),
C-Sst2 (1.7-fold), or no Sst2 (vector control, 1.8-fold) (Fig. 1).
These data indicate that N-Sst2 is a potent activator of the stress
response pathway, but the high basal activity leads to a diminished
salt induction.
High concentrations of NaCl are known to inhibit cell growth, in
addition to stimulating expression of STREs. Moreover, a number of
mutants with disrupted signaling to STRE genes will grow poorly in high
osmolarity medium (50). Thus, we examined whether N-Sst2 (or C-Sst2)
has any effect on growth in high salt. Saturated cultures were diluted
and spotted onto solid medium, either in the absence or presence of
0.75 M NaCl. In the absence of salt, cells expressing
full-length Sst2, N-Sst2, or vector grew equally well (Fig.
2, top left
panel). The growth of these strains was impaired to a
similar extent in salt-containing medium (Fig. 2, bottom
left panel). In contrast, cells expressing C-Sst2 grew more poorly than the other transformed strains, in the absence or
presence of salt. These results parallel the HSP12-lacZ
reporter transcription data presented in Fig. 1. Since the
C-Sst2-containing cells are unable to express normal amounts of an
STRE-containing gene, they are evidently unable to mount a full
response to stress growth conditions. Even in normal medium, the growth
of the C-Sst2 cells is impaired, as if they were exposed to salt.
Conversely, N-Sst2 expression mimics the transcriptional induction
observed with salt treatment, and these cells are able to grow well in the absence or presence of high salt concentrations.

View larger version (132K):
[in this window]
[in a new window]
|
Fig. 2.
Stress-mediated growth inhibition: N-Sst2
versus C-Sst2. An sst2 mutant strain (YDM400) was
transformed with a plasmid containing full-length SST2,
SST2P20L, N-SST2, C-SST2,
or no insert (Vector; pRS316-ADH). Cells were grown to
saturation, diluted to A600 ~ 0.2, grown to
A600 ~ 0.8, and then treated with 10 µM -factor (final concentration) or water for 2 h. 10 µl of cells were spotted onto solid synthetic medium containing
0.75 M NaCl either without dilution or diluted 1:10, 1:100,
1:1,000, 1:10,000, and 1:100,000 with water or with 10 µM
-factor (as indicated). Resulting growth was documented after
24 h.
|
|
We then examined if pheromone treatment would alter the growth of cells
expressing N-Sst2 or C-Sst2, in the absence or presence of salt.
Pheromone is known to impair growth, leading to cell cycle arrest in
G1. Cells lacking SST2 are supersensitive to
pheromone-induced growth arrest. However, we have previously shown that
neither N-Sst2 nor C-Sst2 alone can rescue an sst2
mutation (18). Consistent with these earlier observations, cells
expressing N-Sst2, C-Sst2, or vector grew poorly in the presence of
pheromone, compared with the full-length protein (Fig. 2,
top right panel). Pheromone-treated cells expressing the gain-of-function mutant Sst2P20L grew
better than those with full-length Sst2, as previously reported (51).
Cells expressing C-Sst2 grew poorly in the presence or absence of high
salt, and even more poorly in the presence of salt plus pheromone (Fig.
2, bottom right panel). This pattern of additive growth inhibition was evident throughout and is consistent with separate and additive mechanisms of action.
Genetic studies have revealed at least two osmosensing pathways that
converge on the MAP kinase kinase Pbs2, leading to tyrosine phosphorylation of the MAP kinase Hog1 (52). MAP kinases are the only
tyrosine-phosphorylated proteins in yeast, and Hog1 is the only MAP
kinase phosphorylated in response to salt stress (52). Thus, we
examined if N-Sst2 or C-Sst2 have any effect on Hog1 phosphorylation,
by immunoblotting whole cell extracts with anti-phosphotyrosine
antibodies. As shown previously (52), salt treatment leads to a
dramatic increase in Hog1 phosphorylation (Fig.
3). However, Hog1 phosphorylation is
largely unaffected by expression of N-Sst2 or C-Sst2, in the absence or
presence of added salt. These results are in contrast to the reporter
transcription assay presented above, in which N-Sst2 stimulated, and
C-Sst2 inhibited, basal expression of HSP12-lacZ. These data
together with those presented in Fig. 2 suggest that N-Sst2 acts
through another, Hog1-independent, pathway.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Stress-mediated Hog1 phosphorylation: N-Sst2
versus C-Sst2. An sst2 mutant
strain (YDM400) was transformed with a plasmid containing no insert
(Vector; pRS316-ADH), N-SST2, C-SST2,
or full-length SST2. Cells were grown to mid-log phase and
treated with NaCl or water for 60 min. Cell lysates were prepared and
subjected to 8% SDS-PAGE and immunoblotting with anti-phosphotyrosine
antibodies to detect phosphorylated-Hog1 (P-Hog1).
|
|
One way to determine the biological role of N-Sst2 is through the
identification of associated proteins. To this end, we carried out a
two-hybrid screen against an array of nearly all yeast open reading
frames. A strain expressing N-Sst2 fused to the Gal4 DNA-binding domain
was mated to a set of ~6,000 colonies, each expressing a unique full
length open reading frame fused to the Gal4 activation domain. Any
proteins identified in two independent screens were analyzed further.
As shown in Table III, N-Sst2
reproducibly yielded 17 putative interactions. This compares to an
average of 3.3 positives per protein obtained for an independent set of
192 DNA binding domain hybrids, described previously (20). Using an
identical screening array, full-length Sst2 yielded no specific
positives. Mpt5, a protein shown to bind Sst2 in a previous two-hybrid
screen, was not identified in our screen. Genetic analysis revealed
that Mpt5 can attenuate pheromone signaling downstream of the G
protein and independently of the C-terminal RGS domain (53,
54).
View this table:
[in this window]
[in a new window]
|
Table III
Genome-wide two-hybrid analysis using N-Sst2 as bait
A strain expressing N-Sst2 fused to the Gal4 DNA-binding domain was
mated to a set of ~6,000 colonies, each expressing a unique
full-length open reading frame fused to the Gal4 activation domain, as
described. Proteins identified in two independent screens with the same
bait are listed. Only genes identified in 10 or fewer screens are
listed, since those identified at a higher frequency are likely to be
nonspecific ("false") positives. Functional descriptions and number
of amino acids (aa) are from the YPD database (note that
MVP1 is erroneously listed in YPD as being required for
vacuolar protein sorting). Predicted conserved sequence motifs are from
the SMART data base (16, 93). TM, transmembrane domain, S/TK,
serine/threonine protein kinases catalytic domain. CC, coiled-coil
domain. SH3, Src homology 3 domain. FH2, formin homology 2 domain. ZnF
RBZ, zinc finger Ran-binding domain. RING, ring finger domain with
possible ubiquitin-protein ligase activity. PX, PhoX homologous domain.
tSNARE, helical region found in SNAREs. SynN, syntaxin N-terminal
domain.
|
|
Of the 17 putative N-Sst2-binding proteins, five (29%) were listed by
the Yeast Protein Data base as unclassified, having no known functional
or structural homologues. This value is similar to the percentage of
unclassified genes listed throughout the entire data base. At least
three of these genes, PEP12, TLG2, and
VPS36, are required for proper sorting of vacuolar proteases and normal vacuolar morphology (55-64). Several other interacting proteins are protein kinases, including Iks1, and a member of the MAP
kinase family Kss1 (KSS1 product, kinase suppressor of sst2). Kss1 can phosphorylate Sst2 at Ser539,
which is located in the C-terminal domain of the protein (65).
We then examined whether any of the potential N-Sst2 binding partners
are required to transmit a signal via the stress response pathway. Gene
deletion mutants were obtained for 15 of the 17 interacting proteins
and evaluated for changes in HSP12-lacZ activity. As shown
in Fig. 4, all three of the vacuolar
sorting mutants, pep12 , tlg2 , and
vps36 , yielded a high basal activity. In addition, these
mutants exhibited a diminished induction with salt treatment (1.4-, 1.8-, and 2.1-fold, respectively) as compared with the wild-type strain
(2.6-fold induction). This pattern of activity (high basal, low
induction) resembles that seen with N-Sst2 in Fig. 1. Our positive
control for this assay was a deletion of the high osmolarity glycerol
kinase gene HOG1 (52). Like N-Sst2 and the binding partner
mutants, the hog1 strain exhibited a diminished induction
with salt (2.1-fold). In contrast to the other mutants, however,
hog1 exhibited a normal or slightly reduced basal
activity. We also tested four other vacuolar sorting mutants, vps5 , vps20 , vps21 , and
vps25 . Vps5 was chosen because it contains a
phosphoinositide-binding Phox homology (PX) domain, which is found in
the mammalian RGS protein RGS-PX1 (66). Vps20 and Vps25 were reported
previously to interact with Vps36 in two-hybrid assays (20, 21). Vps21
was chosen arbitrarily as a negative control to rule out the
possibility that altered STRE signaling is a generalized consequence of
impaired vacuolar function. As shown in Fig. 4, all four mutants
exhibited normal basal and salt-induced activities. Taken together,
these data indicate that PEP12, TLG2, and
VPS36 are necessary for full activation of the stress
response pathway but act in a manner distinct from the well
characterized Hog1 kinase.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Loss of N-Sst2-binding proteins induces a
stress-activated promoter. Wild-type and gene disruption mutants
were transformed with a plasmid containing the stress-activated
HSP12 promoter and lacZ reporter gene
(pRS423-HSP12-lacZ). Cells were grown to mid-log phase and treated with
0.75 M NaCl or water for 10 min, and the resulting
-galactosidase activity was measured as described under
"Experimental Procedures." Data shown are typical of three
independent experiments performed in triplicate. Error
bars, ±S.E.
|
|
Sst2 is well known to regulate pheromone signaling. An
sst2 mutant can enhance pheromone sensitivity by
>100-fold. Thus, we then examined if any of the 15 candidate binding
partners could also regulate the pheromone response. For these
experiments, two standard bioassays were used. In the halo assay, cells
are spread onto solid media and exposed to -factor pheromone
spotted onto filter disks. The resulting zone of growth inhibition
gives an indication of pheromone response (halo size) and recovery
(halo turbidity). Of the 15 mutants tested, only vps36 ,
pep12 , and tlg2 produced more turbid zones
of growth inhibition, as compared with the wild-type control,
indicating an enhanced ability to recover from pheromone-induced growth
arrest. An additional mutant (kel1 ) had the opposite
effect, producing halos that were slightly larger and less turbid than
the wild-type control (Fig.
5A).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Loss of N-Sst2-binding proteins inhibits the
pheromone response pathway. A, wild-type and mutant
strains were plated, and the nascent lawn was exposed to sterile filter
discs spotted with -factor (from bottom clockwise: 15, 25, 50, and 75 µg for 48 h) and then photographed. The wild-type strain BY4741
is a negative control, and the isogenic fus3 strains are
a positive control. Other mutants tested but not shown
(vps5 , vps20 , vps21 ,
vps25 , vps35 , and vps38 ) also
produced slightly turbid halos. B, wild-type and mutant
strains were transformed with a plasmid containing the
pheromone-responsive FUS1 promoter-lacZ reporter.
Cells were then treated with the indicated concentrations of
-factor, and the resulting -galactosidase activity was measured
as described under "Experimental Procedures." Data shown are
typical of three independent experiments performed in triplicate.
Error bars, ±S.E.
|
|
A number of vacuolar sorting mutants have previously been reported to
produce turbid halos (67). Halo turbidity in the vacuolar sorting
mutants could result from missorting and secretion of vacuolar
proteases and the consequent proteolysis of pheromone or the pheromone
receptors. Indeed, we found that each of the vps mutants
tested (vps5 , vps20 , vps21 ,
vps25 , vps35 , vps38 ) also
yielded slightly turbid halos (data not shown). To provide an
independent assessment of pheromone sensitivity, we tested each of the
candidate binding partners using a pheromone-responsive transcription
reporter assay (FUS1 promoter, lacZ reporter). In agreement with the results of the halo assay, vps36 ,
pep12 , and tlg2 exhibited a diminished
transcription response (Fig. 5B, top
panel). The effects were particularly dramatic for the vps36 and tlg2 mutants, with reductions of
30 and 50%, respectively. Deletion of two candidate
Vps36-binding partners (vps20 , vps25 ) also
resulted in a diminished response, equal to or greater than that
exhibited by vps36 (Fig. 5B, middle). One of
the control mutants (vps5 ) responded like wild-type,
while a second (vps21 ) had a diminished response.
Therefore, two additional control mutants (vps35 and
vps38 , selected arbitrarily) were tested and found to
also respond like wild-type (Fig. 5B, bottom). Thus, in addition to their role in stress response signaling, VPS36, TLG2, and PEP12 are also
necessary for full activation of the pheromone response pathway. The
pheromone signaling phenotype is seen with some but not all
vps mutants. The stress signaling phenotype is not shared by
any of the other vps mutants. Taken together, these data
indicate that Vps36, Tlg2, and Pep12 function in a manner similar to
N-Sst2 but distinct from other vacuolar sorting factors.
Because it has an especially strong pheromone signaling phenotype and
because it has not been well characterized previously, we selected
Vps36 for further analysis. We first showed that a plasmid-borne copy
of Vps36 could reverse the pheromone-resistant phenotype of the
vps36 mutation (Fig.
6A). Overexpression of Vps36
in a wild-type strain did not further enhance signaling and even had a
modest inhibitory effect (Fig. 6, A and B).
However, overexpression of Vps36 in cells lacking SST2 did
result in a dramatic elevation of pheromone sensitivity (Fig.
6B). The signal-enhancing effects of Vps36 may be unmasked
when Sst2 protein levels are low, as occurs in the absence of pheromone
(30).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Overexpression of VPS36 enhances pheromone
response signaling. Wild-type, vps36 (A),
and sst2 (B) cells were transformed with a
plasmid containing the FUS1-lacZ reporter and a plasmid
(pYES2.1/V5-His-TOPO) containing either no insert (vector)
or VPS36 (pVPS36). Cells were treated with the indicated
concentrations of -factor, and the resulting -galactosidase
activity was measured as detailed under "Experimental Procedures."
A greater loss of signaling was observed in this experiment as compared
with Fig. 5, evidently due to the use of galactose-containing
media. Data shown are typical of three independent experiments
performed in quadruplicate. Error bars,
±S.E.
|
|
Having shown that Vps36 activity is diminished by Sst2, we next
examined whether Sst2 activity is similarly dependent on Vps36. Overexpression of full-length SST2 is well known to inhibit
the pheromone response (30). Overexpression of Sst2 also reduces the
already diminished response of the vps36 strain (Fig.
7), indicating that Sst2 can inhibit
signaling in the absence of Vps36. In contrast, overexpression of
N-Sst2 has no effect on signaling in a wild-type
strain (Fig. 2) (18). Presumably, this is because N-Sst2 lacks the
GTPase accelerating activity associated with the C-terminal RGS domain.
Remarkably, N-Sst2 is a potent inhibitor in the vps36
mutant and is even more active than full-length Sst2 (Fig. 7). Thus, a
signal-dampening effect of Sst2 is unmasked when Vps36 is absent, and
this effect resides in the N-Sst2 domain. These data suggest an
antagonistic relationship between Vps36 and Sst2, in their
ability to regulate the pheromone response pathway.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 7.
Loss of Vps36 enhances the activity of
N-Sst2. Wild-type and vps36 cells were transformed
with a plasmid containing the FUS1-lacZ reporter and a
plasmid (pYES2.1/V5-His-TOPO) containing either no insert
(vector), N-SST2 (pN-SST2), or full-length
SST2 (pSST2). Cells were treated with the indicated
concentrations of -factor, and -galactosidase activity was
determined as detailed under "Experimental Procedures." Data shown
are typical of three independent experiments performed in
quadruplicate. Error bars, ± S.E.
|
|
Sst2 is well known to attenuate signaling through its ability to
accelerate G GTPase activity. Thus, we examined whether Vps36 also
acts through the G protein subunit or if it affects signaling
downstream of the G protein. G -independent signaling was achieved
through overexpression of STE4 (G ), mutational activation of STE11 (effector kinase), and overexpression of
STE12 (transcription factor). Overexpression of
STE4 results in elevated levels of the G complex,
above that which can bind to G (68-70). The STE11-4 mutant encodes a constitutively active form of the mitogen-activated protein kinase kinase kinase, Ste11 (34). Overexpression of STE12 results in elevated transcription of PRE-containing
genes (71). As shown in Fig. 8, the
vps36 mutant attenuated signaling by at least 25% in
every case, whether or not -factor was added. These data suggest
that Vps36 can function downstream of the G protein, independently of
Sst2 RGS activity, and most likely at the level of transcription.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 8.
Vps36 acts late in the pathway.
Wild-type and vps36 cells were transformed with a plasmid
containing the FUS1-lacZ reporter and a plasmid containing
no insert (vector) or a plasmid that confers overexpression
of G (pSTE4) (A), expression of activated allele of
Ste11 (pSTE11-4) (B), or overexpression of the
transcription factor Ste12 (pSTE12) (C). Cells were treated
with the indicated concentration of -factor, and the resulting
-galactosidase activity was measured as detailed under
"Experimental Procedures." Data shown are typical of three
independent experiments performed in quadruplicate. Error
bars, ±S.E.
|
|
 |
DISCUSSION |
The GTPase accelerating activity of RGS proteins is well
established. However, many RGS family members are likely to have other
functions as well. Our goal was to identify a possible signaling function for the N-terminal (non-RGS-homologous) domain of Sst2. Yeast
has specific advantages for this type of investigation, since nearly
every gene has been arrayed for RNA expression studies, subjected to
two-hybrid analysis, and genetically disrupted. Here, a comprehensive
analysis of transcription indicates that N-Sst2 regulates a pathway
leading to STRE activation. Comprehensive two-hybrid analysis has
revealed candidate targets of N-Sst2 action. The functional
significance of some of these interactions was established using gene
disruption mutations, in conjunction with functional assays of stress-
and pheromone-mediated signaling in yeast. Of the 17 proteins
identified as potential N-Sst2 interactors, at least one has previously
been implicated in STRE activation. Sho1 is thought to act by
recruiting the MAP kinase kinase Pbs2 to the plasma membrane (72-74).
Pbs2 phosphorylates Hog1, which in turn activates the transcription
factors Msn2 and Msn4 (48, 75). Msn2/4 are known to bind to the CCCCT
motif present in stress-activated genes (46, 47, 76, 77). Not
surprisingly, deletion of MSN2 and MSN4 results
in poor growth and decreased induction of STRE-regulated genes upon
exposure to high osmolarity media, heat shock, nutrient
limitation, and oxidative stresses (46, 47, 77). However, our analysis
indicates that binding of N-Sst2 to Sho1 is of little functional
consequence, at least with respect to Hog1 phosphorylation (Fig. 3).
Moreover, the pattern of HSP12-lacZ activation by N-Sst2
resembles that of the N-Sst2 binding partner mutants (high basal, low
salt induction) (Fig. 1) but is substantially different from that of
the hog1 mutant (normal basal, low salt induction) (Fig.
4).
Another pathway suggested to contribute to the stress response involves
Gpa2 (the only other G protein in yeast besides Gpa1) (78). Gpa2 is
activated by a putative glucose receptor, Gpr1, and transmits a signal
leading to activation of adenylyl cyclase and the
cAMP-dependent protein kinase. Gene profiling studies have
been conducted following activation of the
cAMP-cAMP-dependent protein kinase pathway (79) and have
revealed 17 genes that are repressed by cAMP, 10 of which are dependent
on MSN2 and MSN4 expression. We noted that eight
of the cAMP-regulated genes show at least a modest increase in cells
expressing N-Sst2, and two of these increase by at least 2-fold:
YAK1 (YJL141C) and YHR033. In comparison, over half the
genes induced by N-Sst2 were previously identified as being induced
after a shift to high osmolarity medium (48). Our data suggest that
STREs may be activated by a distinct signaling pathway that is
dependent on N-Sst2. Whole genome two-hybrid analysis revealed three
components that also modulate transcription of an STRE-containing gene.
Prior data have indicated that all three proteins are necessary for
different aspects of protein trafficking and vacuolar function in yeast
cells. Tlg2 is a syntaxin (t-SNARE) that functions in transport from
the endosome to the late Golgi within the endocytic pathway (55, 56).
Pep12 is a syntaxin that is required for protein sorting between the
Golgi and endosome (57, 58). Vps36 is one of a diverse class of gene
products needed for protein trafficking from the pre-vacuolar compartment to the vacuole (59-62). Notably, an earlier screen yielded
a number of mutants with altered vacuolar function and diminished growth in high salt (63, 64). We have observed that this
salt-sensitive growth phenotype is shared by the vps36 , tlg2 , and pep12 mutants (data not shown).
This could result from altered signaling to STREs or more likely from
defects in the transport of proteins that mediate osmotic regulation.
STRE activation is not a general phenotype of vacuolar sorting mutants, however (Fig. 4).
An important question is whether the Vps36, Tlg2, and Pep12 bind
physically to N-Sst2 or if they exert their documented
functional effects through some common bridging protein. So
far, direct binding of N-Sst2 to Vps36 and Tlg2 has been demonstrated
using synthetic peptide arrays
(80).3 This analysis revealed
binding to three discontinuous peptide "epitopes" within Vps36 and
a single segment within Tlg2. This approach is also currently being
used to identify the epitope(s) within N-Sst2 recognized by Vps36 and Tlg2.
Another significant question is whether Sst2 (like its putative binding
partners) participates in protein sorting. This seems likely, since
there is already considerable evidence that RGS proteins can regulate
vesicle-mediated trafficking processes in other organisms. The
mammalian RGS protein GAIP is associated with endoplasmic reticulum,
Golgi, newly budded Golgi vesicles, and clathrin-coated vesicles (81,
82). GAIP appears to regulate secretion in epithelial cell lines (83)
and lysosomal-autophagic catabolism in human colon cancer cells (84).
Very recently, Farquhar and colleagues have described a new protein
called RGS-PX1, which contains an RGS domain as well as a PX domain
similar to those in sorting nexin proteins (66). PX domains appear to
help proteins reach their appropriate intracellular location through direct binding of membrane-restricted phosphoinositides (85). In this
regard, sorting nexins interact directly with endocytosed receptors,
such as receptor tyrosine kinases activated by epidermal growth factor,
but also have more general effects on endosomal traffic. RGS-PX1 was
shown to accelerate GTP hydrolysis and inhibit signaling by
Gs and also to delay lysosomal degradation and
inactivation of the epidermal growth factor receptor (66). Because of
its bifunctional role as both a GTPase-accelerating protein and as a
sorting nexin, RGS-PX1 may link heterotrimeric G protein signaling and
vesicular trafficking in mammals. Sst2 might similarly link G protein
signaling and vacuolar sorting in yeast. Sst2 is expressed only in
haploid cells, however, so any membrane trafficking function would
probably occur only in conjunction with mating. Another possibility is
that Sst2 and Vps36 regulate transcription. Recently, Vps36 was
reported to bind to Snf8, Vps25 (Yjr102), and Vps20 (20, 21). The human
RNA polymerase II elongation factor-associated proteins EAP45 (or
CGI-145, Fig. 9A), EAP30, and
EAP20 appear to be homologous with Vps36, Snf8, and Vps25,
respectively. The human EAPs form a complex that can inhibit elongation
factor repression of RNA polymerase II activity (86-88). Likewise, a
similar complex of Vps36, Snf8, and Vps25 might derepress RNA
polymerase II in yeast. This could explain the absence of
SUC2 derepression in snf8 ,
vps36 , and vps25 mutants (86, 89). It could
also explain how VPS36 can coordinately regulate vacuolar
trafficking and pheromone signaling. Vps36 must regulate STRE
transcription by a distinct pathway, however, since the effects on this
promoter occur independently of putative binding partners Vps25 and
Vps20. Snf8 was not tested because of technical
difficulties with the reporter transcription assay in the available
knockout strain. Thus, our genetic analysis in yeast and parallel
studies in human cells suggest that Vps36 acts at the level of
transcription. Notably, we have identified a simple pattern-7 nuclear
localization signal (NLS; Fig. 9B) and two novel
zinc finger Ran-GDP binding domains (RBZ domain; Fig. 9B).
Residues 120-186 could also form a RING finger domain, which is a
specialized type of zinc finger involved in protein-protein
interactions, including binding to E2 ubiquitin-conjugating enzymes
(90). The RBZ domain may serve to recruit Vps36 to Ran-GDP. RanGDP is
found nearly exclusively in the cytoplasm and the cytoplasmic face of
the nuclear pore complex (91). The nuclear localization signal suggests
that Vps36 may exist in the nucleus or shuttle between the cytoplasm
and nucleus via the nuclear pore complex (92). However, while the RBZs
and nuclear localization signal are present within the S. cerevisiae and Schizosaccharomyces pombe proteins, they
are absent from Vps36 homologues in higher organisms (see Fig.
9A; data not shown).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 9.
Vps36 and its homologues. A,
rectangular cladogram of Vps36 homologues. Some homologues to Vps36
were identified using advanced BLAST. Using an E value
threshold of 0.01, PSI-BLAST revealed additional Vps36 homologues:
CGI-145 (EAP45; E = 1 × 10 59),
AK023082 (E = 5 × 10 57), and
MUG13.23 (E = 3 × 10 58), all with
two iterations. A third iteration identified L4520.06
(E = 6 × 10 6). Additional
iterations produced no further sequence hits, demonstrating
convergence. SP, S. pombe; Lm,
Leishmania major; At, Arabadopsis
thaliania; Ce, C. elegans; h,
Homo sapiens; d, Drosophila
melanogaster. B, Vps36 has two RBZ zinc binding Ran-GDP
binding domains (above left, E = 0.65; above right, E = 1.9 × 10 4) with conserved Cys residues
(underlined) as well as a nuclear localization signal of the
pattern-7 type (below). C, schematic
diagram summarizing the observed effects of Vps36 and N-Sst2
in STRE-lacZ and PRE-lacZ reporter assays.
Arrow, stimulator; bar, inhibitor.
|
|
In conclusion, Sst2 is one of a growing list of RGS proteins with at
least two signaling functions. We have shown that Vps36 and the N-Sst2
domain can cooperatively regulate both the pheromone and stress
response pathways. Whereas the pheromone response is inhibited by
N-Sst2 and activated by Vps36, the stress response is activated by
N-Sst2 and inhibited by Vps36 (Fig. 9C). The identification of candidate N-Sst2 binding proteins and their demonstrated role in
stress signaling will be extremely useful in addressing the mechanism
by which these proteins function within the cell. The approach used
here also serves as a model for an integrated analysis of signaling
pathways in other systems. Such an approach will be important for the
identification and characterization of a large number of unknown gene
products as they are identified through genome sequencing programs.
 |
FOOTNOTES |
*
This work was supported by a pilot grant from the Claude D. Pepper Center of Yale University (to S. A. B.) and National
Institutes of Health Grants P41 RR11823 (to S. F.) and GM55316 and
GM59167 (to H. G. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: NCI, National Institutes of Health, Neuro-Oncology
Branch, Convent Dr., Bldg. 36, Rm. 3B-02, Bethesda, MD 20892.
¶
Present address: Dept. of Biochemistry and Biophysics,
University of North Carolina, 405 Mary Ellen Jones Bldg., Campus Box 7260, Chapel Hill, NC 27599-2852.

Present address: Institut für Genetik, Forschungszentrum
Karlsruhe, PO Box 3640, D-76021 Karlsruhe, Germany.
¶¶
An Investigator of the Howard Hughes Medical Institute.

An Established Investigator of the American Heart
Association. To whom correspondence should be addressed: Dept. of
Biochemistry and Biophysics, University of North Carolina at Chapel
Hill, 405 Mary Ellen Jones Bldg., Campus Box 7260, Chapel Hill, NC
27599-2852. Tel.: 919-843-6894; Fax: 919-966-2852; E-mail:
henrik_dohlman@med.unc.edu.
Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M202254200
2
P. Flanary and H. Dohlman, manuscript in preparation.
3
P. Uetz, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
RGS, regulator of G
protein signaling;
DEP, Dishevelled, Egl-10, and pleckstrin;
STRE, stress response element;
MES, 4-morpholineethanesulfonic acid;
PRE, pheromone response element;
STRE, stress response element;
MAP, mitogen-activated protein;
PX, Phox homology;
EAP, elongation
factor-associated protein;
PIPES, 1,4-piperazinediethanesulfonic
acid.
 |
REFERENCES |
| 1.
|
Dohlman, H. G.,
and Thorner, J. W.
(2001)
Annu. Rev. Biochem.
70,
703-754[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Burchett, S. A.
(2000)
J. Neurochem.
75,
1335-1351[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Popov, S., Yu, K.,
Kozasa, T.,
and Wilkie, T. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7216-7220[Abstract/Free Full Text]
|
| 4.
|
Snow, B. E.,
Krumins, A. M.,
Brothers, G. M.,
Lee, S. F.,
Wall, M. A.,
Chung, S.,
Mangion, J.,
Arya, S.,
Gilman, A. G.,
and Siderovski, D. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13307-13312[Abstract/Free Full Text]
|
| 5.
|
Siderovski, D. P.,
Diverse-Pierluissi, M.,
and De Vries, L.
(1999)
Trends Biochem. Sci.
24,
340-341[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Cabrera, J. L.,
de Freitas, F.,
Satpaev, D. K.,
and Slepak, V. Z.
(1998)
Biochem. Biophys. Res. Commun.
249,
898-902[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Kim, E.,
Arnould, T.,
Sellin, L.,
Benzing, T.,
Comella, N.,
Kocher, O.,
Tsiokas, L.,
Sukhatme, V. P.,
and Walz, G.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6371-6376[Abstract/Free Full Text]
|
| 8.
|
Benzing, T.,
Yaffe, M. B.,
Arnould, T.,
Sellin, L.,
Schermer, B.,
Schilling, B.,
Schreiber, R.,
Kunzelmann, K.,
Leparc, G. G.,
Kim, E.,
and Walz, G.
(2000)
J. Biol. Chem.
275,
28167-28172[Abstract/Free Full Text]
|
| 9.
|
De Vries, L.,
Lou, X.,
Zhao, G.,
Zheng, B.,
and Farquhar, M. G.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12340-12345[Abstract/Free Full Text]
|
| 10.
|
Carman, C. V.,
Parent, J. L.,
Day, P. W.,
Pronin, A. N.,
Sternweis, P. M.,
Wedegaertner, P. B.,
Gilman, A. G.,
Benovic, J. L.,
and Kozasa, T.
(1999)
J. Biol. Chem.
274,
34483-34492[Abstract/Free Full Text]
|
| 11.
|
Usui, H.,
Nishiyama, M.,
Moroi, K.,
Shibasaki, T.,
Zhou, J.,
Ishida, J.,
Fukamizu, A.,
Haga, T.,
Sekiya, S.,
and Kimura, S.
(2000)
Int. J. Mol. Med.
5,
335-340[Medline]
[Order article via Infotrieve]
|
| 12.
|
Sallese, M.,
Mariggio, S.,
D'Urbano, E.,
Iacovelli, L.,
and De Blasi, A.
(2000)
Mol. Pharmacol.
57,
826-831[Abstract/Free Full Text]
|
| 13.
|
Schiff, M. L.,
Siderovski, D. P.,
Jordan, J. D.,
Brothers, G.,
Snow, B., De,
Vries, L.,
Ortiz, D. F.,
and Diverse-Pierluissi, M.
(2000)
Nature
408,
723-727[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Hart, M. J.,
Jiang, X.,
Kozasa, T.,
Roscoe, W.,
Singer, W. D.,
Gilman, A. G.,
Sternweis, P. C.,
and Bollag, G.
(1998)
Science
280,
2112-2114[Abstract/Free Full Text]
|
| 15.
|
Kozasa, T.,
Jiang, X.,
Hart, M. J.,
Sternweis, P. M.,
Singer, W. D.,
Gilman, A. G.,
Bollag, G.,
and Sternweis, P. C.
(1998)
Science
280,
2109-2111[Abstract/Free Full Text]
|
| 16.
|
Schultz, J.,
Copley, R. R.,
Doerks, T.,
Ponting, C. P.,
and Bork, P.
(2000)
Nucleic Acids Res.
28,
231-234[Abstract/Free Full Text]
|
| 17.
|
Koelle, M. R.,
and Horvitz, H. R.
(1996)
Cell
84,
115-125[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Hoffman, G. A.,
Garrison, T. R.,
and Dohlman, H. G.
(2000)
J. Biol. Chem.
275,
37533-37541[Abstract/Free Full Text]
|
| 19.
|
Lockhart, D. J.,
and Winzeler, E. A.
(2000)
Nature
405,
827-836[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Uetz, P.,
Giot, L.,
Cagney, G.,
Mansfield, T. A.,
Judson, R. S.,
Knight, J. R.,
Lockshon, D.,
Narayan, V.,
Srinivasan, M.,
Pochart, P.,
Qureshi-Emili, A., Li, Y.,
Godwin, B.,
Conover, D.,
Kalbfleisch, T.,
Vijayadamodar, G.,
Yang, M.,
Johnston, M.,
Fields, S.,
and Rothberg, J. M.
(2000)
Nature
403,
623-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Ito, T.,
Chiba, T.,
Ozawa, R.,
Yoshida, M.,
Hattori, M.,
and Sakaki, Y.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4569-4574[Abstract/Free Full Text]
|
| 22.
|
Pandey, A.,
and Mann, M.
(2000)
Nature
405,
837-846[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Gavin, A. C.,
Bosche, M.,
Krause, R.,
Grandi, P.,
Marzioch, M.,
Bauer, A.,
Schultz, J.,
Rick, J. M.,
Michon, A. M.,
Cruciat, C. M.,
Remor, M.,
Hofert, C.,
Schelder, M.,
Brajenovic, M.,
Ruffner, H.,
Merino, A.,
Klein, K.,
Hudak, M.,
Dickson, D.,
Rudi, T.,
Gnau, V.,
Bauch, A.,
Bastuck, S.,
Huhse, B.,
Leutwein, C.,
Heurtier, M. A.,
Copley, R. R.,
Edelmann, A.,
Querfurth, E.,
Rybin, V.,
Drewes, G.,
Raida, M.,
Bouwmeester, T.,
Bork, P.,
Seraphin, B.,
Kuster, B.,
Neubauer, G.,
and Superti-Furga, G.
(2002)
Nature
415,
141-147[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Gygi, S. P.,
Rist, B.,
Gerber, S. A.,
Turecek, F.,
Gelb, M. H.,
and Aebersold, R.
(1999)
Nat. Biotechnol.
17,
994-999[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Verma, R.,
Chen, S.,
Feldman, R.,
Schieltz, D.,
Yates, J.,
Dohmen, J.,
and Deshaies, R. J.
(2000)
Mol. Biol. Cell
11,
3425-3439[Abstract/Free Full Text]
|
| 26.
|
Ho, Y.,
Gruhler, A.,
Heilbut, A.,
Bader, G. D.,
Moore, L.,
Adams, S. L.,
Millar, A.,
Taylor, P.,
Bennett, K.,
Boutilier, K.,
Yang, L.,
Wolting, C.,
Donaldson, I.,
Schandorff, S.,
Shewnarane, J., Vo, M.,
Taggart, J.,
Goudreault, M.,
Muskat, B.,
Alfarano, C.,
Dewar, D.,
Lin, Z.,
Michalickova, K.,
Willems, A. R.,
Sassi, H.,
Nielsen, P. A.,
Rasmussen, K. J.,
Andersen, J. R.,
Johansen, L. E.,
Hansen, L. H.,
Jespersen, H.,
Podtelejnikov, A.,
Nielsen, E.,
Crawford, J.,
Poulsen, V.,
Sorensen, B. D.,
Matthiesen, J.,
Hendrickson, R. C.,
Gleeson, F.,
Pawson, T.,
Moran, M. F.,
Durocher, D.,
Mann, M.,
Hogue, C. W.,
Figeys, D.,
and Tyers, M.
(2002)
Nature
415,
180-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Winzeler, E. A.,
Shoemaker, D. D.,
Astromoff, A.,
Liang, H.,
Anderson, K.,
Andre, B.,
Bangham, R.,
Benito, R.,
Boeke, J. D.,
Bussey, H.,
Chu, A. M.,
Connelly, C.,
Davis, K.,
Dietrich, F.,
Dow, S. W., El,
Bakkoury, M.,
Foury, F.,
Friend, S. H.,
Gentalen, E.,
Giaever, G.,
Hegemann, J. H.,
Jones, T.,
Laub, M.,
Liao, H.,
Davis, R. W.,
et al..
(1999)
Science
285,
901-906[Abstract/Free Full Text]
|
| 28.
|
Boulton, S. J.,
Gartner, A.,
Reboul, J.,
Vaglio, P.,
Dyson, N.,
Hill, D. E.,
and Vidal, M.
(2002)
Science
295,
127-131[Abstract/Free Full Text]
|
| 29.
|
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K.
(eds)
(1987)
Current Protocols in Molecular Biology
, Greene/Wiley-Interscience, New York
|
| 30.
|
Dohlman, H. G.,
Song, J., Ma, D.,
Courchesne, W. E.,
and Thorner, J.
(1996)
Mol. Cell. Biol.
16,
5194-5209[Abstract]
|
| 31.
|
Sikorski, R. S.,
and Hieter, P.
(1989)
Genetics
122,
19-27[Abstract/Free Full Text]
|
| 32.
|
Song, J.,
Hirschman, J.,
Gunn, K.,
and Dohlman, H. G.
(1996)
J. Biol. Chem.
271,
20273-20283[Abstract/Free Full Text]
|
| 33.
|
Dohlman, H. G.,
Apaniesk, D.,
Chen, Y.,
Song, J.,
and Nusskern, D.
(1995)
Mol. Cell. Biol.
15,
3635-3643[Abstract]
|
| 34.
|
Stevenson, B. J.,
Rhodes, N.,
Errede, B.,
and Sprague, G. F., Jr.
(1992)
Genes Dev.
6,
1293-1304[Abstract/Free Full Text]
|
| 35.
|
Cagney, G.,
Uetz, P.,
and Fields, S.
(2000)
Methods Enzymol.
328,
3-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Wodicka, L.,
Dong, H.,
Mittmann, M., Ho, M. H.,
and Lockhart, D. J.
(1997)
Nat. Biotechnol.
15,
1359-1367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Hill, A. A.,
Hunter, C. P.,
Tsung, B. T.,
Tucker-Kellogg, G.,
and Brown, E. L.
(2000)
Science
290,
809-812[Abstract/Free Full Text]
|
| 38.
|
Moskvina, E.,
Schuller, C.,
Maurer, C. T.,
Mager, W. H.,
and Ruis, H.
(1998)
Yeast
14,
1041-1050[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Roth, F. P.,
Hughes, J. D.,
Estep, P. W.,
and Church, G. M.
(1998)
Nat. Biotechnol.
16,
939-945[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402[Abstract/Free Full Text]
|
| 41.
|
Jeanmougin, F.,
Thompson, J. D.,
Gouy, M.,
Higgins, D. G.,
and Gibson, T. J.
(1998)
Trends Biochem. Sci
23,
403-405[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Page, R. D.
(1996)
Comput. Appl. Biosci.
12,
357-358[Free Full Text]
|
| 43.
|
Nakai, K.,
and Kanehisa, M.
(1992)
Genomics
14,
897-911[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Apanovitch, D. M.,
Slep, K. C.,
Sigler, P. B.,
and Dohlman, H. G.
(1998)
Biochemistry
37,
4815-4822[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Moskvina, E.,
Imre, E. M.,
and Ruis, H.
(1999)
Mol. Microbiol.
32,
1263-1272[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Martinez-Pastor, M. T.,
Marchler, G.,
Schuller, C.,
Marchler-Bauer, A.,
Ruis, H.,
and Estruch, F.
(1996)
EMBO J.
15,
2227-2235[Medline]
[Order article via Infotrieve]
|
| 47.
|
Schmitt, A. P.,
and McEntee, K.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5777-5782[Abstract/Free Full Text]
|
| 48.
|
Rep, M.,
Krantz, M.,
Thevelein, J. M.,
and Hohmann, S.
(2000)
J. Biol. Chem.
275,
8290-8300[Abstract/Free Full Text]
|
| 49.
|
Marchler, G.,
Schuller, C.,
Adam, G.,
and Ruis, H.
(1993)
EMBO J.
12,
1997-2003[Medline]
[Order article via Infotrieve]
|
| 50.
|
Varela, J. C.,
Praekelt, U. M.,
Meacock, P. A.,
Planta, R. J.,
and Mager, W. H.
(1995)
Mol. Cell. Biol.
15,
6232-6245[Abstract]
|
| 51.
|
DiBello, P. R.,
Garrison, T. R.,
Apanovitch, D. M.,
Hoffman, G.,
Shuey, D. J.,
Mason, K.,
Cockett, M. I.,
and Dohlman, H. G.
(1998)
J. Biol. Chem.
273,
5780-5784[Abstract/Free Full Text]
|
| 52.
|
Brewster, J. L.,
de Valoir, T.,
Dwyer, N. D.,
Winter, E.,
and Gustin, M. C.
(1993)
Science
259,
1760-1763[Abstract/Free Full Text]
|
| 53.
|
Xu, B. E.,
Skowronek, K. R.,
and Kurjan, J.
(2001)
Genetics
159,
1559-1571[Abstract/Free Full Text]
|
| 54.
|
Chen, T.,
and Kurjan, J.
(1997)
Mol. Cell. Biol.
17,
3429-3439[Abstract]
|
| 55.
|
Abeliovich, H.,
Grote, E.,
Novick, P.,
and Ferro-Novick, S.
(1998)
J. Biol. Chem.
273,
11719-11727[Abstract/Free Full Text]
|
| 56.
|
Holthuis, J. C.,
Nichols, B. J.,
Dhruvakumar, S.,
and Pelham, H. R.
(1998)
EMBO J.
17,
113-126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Becherer, K. A.,
Rieder, S. E.,
Emr, S. D.,
and Jones, E. W.
(1996)
Mol. Biol. Cell
7,
579-594[Abstract]
|
| 58.
|
Gerrard, S. R.,
Levi, B. P.,
and Stevens, T. H.
(2000)
Traffic
1,
259-269[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Nothwehr, S. F.,
Bryant, N. J.,
and Stevens, T. H.
(1996)
Mol. Cell. Biol.
16,
2700-2707[Abstract]
|
| 60.
|
Rothman, J. H.,
Howald, I.,
and Stevens, T. H.
(1989)
EMBO J.
8,
2057-2065[Medline]
[Order article via Infotrieve]
|
| 61.
|
Luo, W.,
and Chang, A.
(2000)
Mol. Biol. Cell
11,
579-592[Abstract/Free Full Text]
|
| 62.
|
Luo, W.,
and Chang, A.
(1997)
J. Cell Biol.
138,
731-746[Abstract/Free Full Text]
|
| 63.
|
Latterich, M.,
and Watson, M. D.
(1991)
Mol. Microbiol.
5,
2417-2426[CrossRef][Medline]
[Order article via Infotrieve]
|
| 64.
|
Latterich, M.,
and Watson, M. D.
(1993)
Biochem. Biophys. Res. Commun.
191,
1111-1117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 65.
|
Garrison, T. R.,
Zhang, Y.,
Pausch, M.,
Apanovitch, D.,
Aebersold, R.,
and Dohlman, H. G.
(1999)
J. Biol. Chem.
274,
36387-36391[Abstract/Free Full Text]
|
| 66.
|
Zheng, B., Ma, Y. C.,
Ostrom, R. S.,
Lavoie, C.,
Gill, G. N.,
Insel, P. A.,
Huang, X. Y.,
and Farquhar, M. G.
(2001)
Science
294,
1939-1942[Abstract/Free Full Text]
|
| 67.
|
Dulic, V.,
and Riezman, H.
(1990)
J. Cell Sci.
97,
517-525[Abstract/Free Full Text]
|
| 68.
|
Nomoto, S.,
Nakayama, N.,
Arai, K.,
and Matsumoto, K.
(1990)
EMBO J.
9,
691-696[Medline]
[Order article via Infotrieve]
|
| 69.
|
Cole, G. M.,
Stone, D. E.,
and Reed, S. I.
(1990)
Mol. Cell. Biol.
10,
510-517[Abstract/Free Full Text]
|
| 70.
|
Whiteway, M.,
Hougan, L.,
and Thomas, D. Y.
(1990)
Mol. Cell. Biol.
10,
217-222[Abstract/Free Full Text]
|
| 71.
|
Dolan, J. W.,
and Fields, S.
(1990)
Genes Dev.
4,
492-502[Abstract/Free Full Text]
|
| 72.
|
Maeda, T.,
Takekawa, M.,
and Saito, H.
(1995)
Science
269,
554-558[Abstract/Free Full Text]
|
| 73.
|
Raitt, D. C.,
Posas, F.,
and Saito, H.
(2000)
EMBO J.
19,
4623-4631[CrossRef][Medline]
[Order article via Infotrieve]
|
| 74.
|
Reiser, V.,
Salah, S. M.,
and Ammerer, G.
(2000)
Nat. Cell Biol.
2,
620-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 75.
|
Inoue, Y.,
Tsujimoto, Y.,
and Kimura, A.
(1998)
J. Biol. Chem.
273,
2977-2983[Abstract/Free Full Text]
|
| 76.
|
Estruch, F.,
and Carlson, M.
(1993)
Mol. Cell. Biol.
13,
3872-3881[Abstract/Free Full Text]
|
| 77.
|
Gorner, W.,
Durchschlag, E.,
Martinez-Pastor, M. T.,
Estruch, F.,
Ammerer, G.,
Hamilton, B.,
Ruis, H.,
and Schuller, C.
(1998)
Genes Dev.
12,
586-597[Abstract/Free Full Text]
|
| 78.
|
Thevelein, J. M.,
and de Winde, J. H.
(1999)
Mol. Microbiol.
33,
904-918[CrossRef][Medline]
[Order article via Infotrieve]
|
| 79.
|
Tadi, D.,
Hasan, R. N.,
Bussereau, F.,
Boy-Marcotte, E.,
and Jacquet, M.
(1999)
Yeast
15,
1733-1745[CrossRef][Medline]
[Order article via Infotrieve]
|
| 80.
|
Reineke, U.,
Volkmer-Engert, R.,
and Schneider-Mergener, J.
(2001)
Curr. Opin. Biotechnol.
12,
59-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 81.
|
Petiot, A.,
Ogier-Denis, E.,
Bauvy, C.,
Cluzeaud, F.,
Vandewalle, A.,
and Codogno, P.
(1999)
Biochem. J.
337,
289-295[Medline]
[Order article via Infotrieve]
|
| 82.
|
De Vries, L.,
Elenko, E.,
McCaffery, J. M.,
Fischer, T.,
Hubler, L.,
McQuistan, T.,
Watson, N.,
and Farquhar, M. G.
(1998)
Mol. Biol. Cell
9,
1123-1134[Abstract/Free Full Text]
|
| 83.
|
Wylie, F.,
Heimann, K., Le, T. L.,
Brown, D.,
Rabnott, G.,
and Stow, J. L.
(1999)
Am. J. Physiol.
276,
C497-C506[Medline]
[Order article via Infotrieve]
|
| 84.
|
Ogier-Denis, E.,
Pattingre, S., El,
Benna, J.,
and Codogno, P.
(2000)
J. Biol. Chem.
275,
39090-39095[Abstract/Free Full Text]
|
| 85.
|
Sato, T. K.,
Overduin, M.,
and Emr, S. D.
(2001)
Science
294,
1881-1885[Abstract/Free Full Text]
|
| 86.
|
Kamura, T.,
Burian, D.,
Khalili, H.,
Schmidt, S. L.,
Sato, S.,
Liu, W. J.,
Conrad, M. N.,
Conaway, R. C.,
Conaway, J. W.,
and Shilatifard, A.
(2001)
J. Biol. Chem.
276,
16528-16533[Abstract/Free Full Text]
|
| 87.
|
Schmidt, A. E.,
Miller, T.,
Schmidt, S. L.,
Shiekhattar, R.,
and Shilatifard, A.
(1999)
J. Biol. Chem.
274,
21981-21985[Abstract/Free Full Text]
|
| 88.
|
Shilatifard, A.,
Lane, W. S.,
Jackson, K. W.,
Conaway, R. C.,
and Conaway, J. W.
(1996)
Science
271,
1873-1876[Abstract]
|
| 89.
|
Yeghiayan, P., Tu, J.,
Vallier, L. G.,
and Carlson, M.
(1995)
Yeast
11,
219-224[CrossRef][Medline]
[Order article via Infotrieve]
|
| 90.
|
Joazeiro, C. A.,
and Weissman, A. M.
(2000)
Cell
102,
549-552[CrossRef][Medline]
[Order article via Infotrieve]
|
| 91.
|
Melchior, F.,
and Gerace, L.
(1998)
Trends Cell Biol.
8,
175-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 92.
|
Nigg, E. A.
(1997)
Nature
386,
779-787[CrossRef][Medline]
[Order article via Infotrieve]
|
| 93.
|
Schultz, J.,
Milpetz, F.,
Bork, P.,
and Ponting, C. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5857-5864[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Fang, Y. Pei, and M. J. Bidochka
A regulator of a G protein signalling (RGS) gene, cag8, from the insect-pathogenic fungus Metarhizium anisopliae is involved in conidiation, virulence and hydrophobin synthesis
Microbiology,
April 1, 2007;
153(4):
1017 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bro, S. Knudsen, B. Regenberg, L. Olsson, and J. Nielsen
Improvement of Galactose Uptake in Saccharomyces cerevisiae through Overexpression of Phosphoglucomutase: Example of Transcript Analysis as a Tool in Inverse Metabolic Engineering
Appl. Envir. Microbiol.,
November 1, 2005;
71(11):
6465 - 6472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Strange
The end of "naive reductionism": rise of systems biology or renaissance of physiology?
Am J Physiol Cell Physiol,
May 1, 2005;
288(5):
C968 - C974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Segers, J. C. Regier, and Donald. L. Nuss
Evidence for a Role of the Regulator of G-Protein Signaling Protein CPRGS-1 in G{alpha} Subunit CPG-1-Mediated Regulation of Fungal Virulence, Conidiation, and Hydrophobin Synthesis in the Chestnut Blight Fungus Cryphonectria parasitica
Eukaryot. Cell,
December 1, 2004;
3(6):
1454 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Martemyanov, P. V. Lishko, N. Calero, G. Keresztes, M. Sokolov, K. J. Strissel, I. B. Leskov, J. A. Hopp, A. V. Kolesnikov, C.-K. Chen, et al.
The DEP Domain Determines Subcellular Targeting of the GTPase Activating Protein RGS9 In Vivo
J. Neurosci.,
November 12, 2003;
23(32):
10175 - 10181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Fraser, R. L. Subaran, C. B. Nichols, and J. Heitman
Recapitulation of the Sexual Cycle of the Primary Fungal Pathogen Cryptococcus neoformans var. gattii: Implications for an Outbreak on Vancouver Island, Canada
Eukaryot. Cell,
October 1, 2003;
2(5):
1036 - 1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Chatterjee and R. A. Fisher
Mild Heat and Proteotoxic Stress Promote Unique Subcellular Trafficking and Nucleolar Accumulation of RGS6 and Other RGS Proteins: ROLE OF THE RGS DOMAIN IN STRESS-INDUCED TRAFFICKING OF RGS PROTEINS
J. Biol. Chem.,
August 8, 2003;
278(32):
30272 - 30282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. OERTLE, M. KLINGER, C. A. O. STUERMER, and M. E. SCHWAB
A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family
FASEB J,
July 1, 2003;
17(10):
1238 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|